Emerging intravesical therapies for the management of BCG-unresponsive NMIBC

CUAJ ARTICLE REVIEW

Responsive image

Emerging intravesical therapies for the management of bacillus Calmette–Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer: Charting a path forward

Your Information

Before proceeding, please enter your information. To receive your certificate, your email and full name must be provided.

First Name

Last Name

Qualifier

Do you give consent to CUA sharing only your name and location to program sponsors?

Yes

The CUA is committed to providing high-quality CPD programs that are fair and balanced. If you have perceived any bias in this presentation or have any feedback, please contact:

Tal Erdman
Coordinator, CPD Programs and Accreditation, Office of Education
185 Dorval, #401, Dorval, QC - H9S 5J9
T: (514) 395-0376 ext. 43 - F: (514) 395-1664
tal.erdman@cua.org